Company Filing History:
Years Active: 2010
Title: Eric J Markel: Innovator in Hepatitis C Research
Introduction
Eric J Markel is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of virology, particularly in the study of Hepatitis C virus (HCV). His innovative work has led to advancements in understanding how different isolates of the virus can be replicated in cell cultures.
Latest Patents
Markel holds a patent for a method to confer cell culture replication activity to different Hepatitis C virus isolates. The patent, titled "Method to confer cell culture replication activity to different Hepatitis C virus isolates," features methods for producing HCV replicons using HCV encoding sequences from various isolates. This invention is based on the discovery of the importance of NS3 amino acid position 470 in conferring cell culture replication activity to different HCV isolates. He has 1 patent to his name.
Career Highlights
Eric J Markel is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in virology.
Collaborations
Throughout his career, Markel has worked alongside notable colleagues such as Jay A Grobler and Osvaldo A Flores. These collaborations have further enhanced his research and innovation in the field of Hepatitis C.
Conclusion
Eric J Markel's contributions to Hepatitis C research exemplify the impact of innovative thinking in the medical field. His work continues to influence the understanding and treatment of this significant viral infection.